Ultra Low-Dose Radiation Therapy in Treating Patients With Stage I-IV Stomach MALT Lymphoma
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This trial studies how well ultra low-dose radiation therapy works in treating patients with
stage I-IV stomach mucosa-associated lymphoid tissue (MALT) lymphoma. Ultra low-dose
radiation therapy may be able to kill tumor cells and shrink tumors while having fewer side
effects in patients with MALT lymphoma.